[go: up one dir, main page]

CY1105465T1 - Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα - Google Patents

Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα

Info

Publication number
CY1105465T1
CY1105465T1 CY20061100301T CY061100301T CY1105465T1 CY 1105465 T1 CY1105465 T1 CY 1105465T1 CY 20061100301 T CY20061100301 T CY 20061100301T CY 061100301 T CY061100301 T CY 061100301T CY 1105465 T1 CY1105465 T1 CY 1105465T1
Authority
CY
Cyprus
Prior art keywords
dosage form
pepilamvanous
liquid preparation
emulsifies
preparation
Prior art date
Application number
CY20061100301T
Other languages
English (en)
Inventor
Liang C. Dong
Patrick S.-L. Wong
Steven D. Espinal
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of CY1105465T1 publication Critical patent/CY1105465T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Γνωστοποιείται μορφή δοσολογίας περιλαμβάνουσα φαρμακευτικό σκεύασμα το οποίο αυτογαλακτωματοποιείται εντός της εν λόγω μορφής δοσολογίας.
CY20061100301T 1998-09-09 2006-03-03 Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα CY1105465T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9961998P 1998-09-09 1998-09-09
PCT/US1999/020332 WO2000013663A1 (en) 1998-09-09 1999-09-03 Dosage form comprising liquid formulation

Publications (1)

Publication Number Publication Date
CY1105465T1 true CY1105465T1 (el) 2010-04-28

Family

ID=22275865

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100301T CY1105465T1 (el) 1998-09-09 2006-03-03 Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα

Country Status (19)

Country Link
EP (1) EP1112060B1 (el)
JP (1) JP2002524407A (el)
KR (1) KR100620292B1 (el)
CN (1) CN1227003C (el)
AT (1) ATE311858T1 (el)
AU (1) AU751086B2 (el)
CA (1) CA2341297C (el)
CY (1) CY1105465T1 (el)
DE (1) DE69928815T2 (el)
DK (1) DK1112060T3 (el)
ES (1) ES2251840T3 (el)
HK (1) HK1038508B (el)
HU (1) HU226669B1 (el)
IL (2) IL141914A0 (el)
NO (1) NO20011217L (el)
NZ (1) NZ510020A (el)
RU (1) RU2227021C2 (el)
WO (1) WO2000013663A1 (el)
ZA (1) ZA200101994B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164163A0 (en) * 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103933017A (zh) * 2014-03-26 2014-07-23 邵娜 一种黄体酮缓释胶囊
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
CN115490316B (zh) * 2022-01-24 2023-09-12 成都理工大学 一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580961A5 (en) * 1972-01-13 1976-10-29 Alza Corp Dispenser - functioning by osmotic pressure using active agents in solid or semi solid form
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
ZA946663B (en) * 1993-08-31 1995-03-31 Alza Corp Dispenser containing hydrophobic agent
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE69431533T2 (de) * 1994-06-13 2003-10-02 Alza Corp., Palo Alto Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations

Also Published As

Publication number Publication date
HK1038508A1 (en) 2002-03-22
HUP0104034A3 (en) 2002-12-28
CA2341297A1 (en) 2000-03-16
CN1227003C (zh) 2005-11-16
CA2341297C (en) 2009-02-24
DE69928815D1 (de) 2006-01-12
CN1316897A (zh) 2001-10-10
HU226669B1 (en) 2009-06-29
AU751086B2 (en) 2002-08-08
ATE311858T1 (de) 2005-12-15
JP2002524407A (ja) 2002-08-06
IL141914A (en) 2008-06-05
HK1038508B (zh) 2006-06-30
KR20010086394A (ko) 2001-09-10
NZ510020A (en) 2003-06-30
ES2251840T3 (es) 2006-05-01
DE69928815T2 (de) 2006-06-29
AU5705199A (en) 2000-03-27
EP1112060A1 (en) 2001-07-04
EP1112060B1 (en) 2005-12-07
WO2000013663A1 (en) 2000-03-16
NO20011217L (no) 2001-05-08
KR100620292B1 (ko) 2006-09-13
RU2227021C2 (ru) 2004-04-20
NO20011217D0 (no) 2001-03-09
HUP0104034A2 (hu) 2002-04-29
DK1112060T3 (da) 2006-04-18
IL141914A0 (en) 2002-03-10
ZA200101994B (en) 2002-03-11

Similar Documents

Publication Publication Date Title
CY1105465T1 (el) Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα
TR199901077A2 (en) �spen�iyari form�lasyonlar.
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69916922D1 (de) Ibuprofenhaltige Arzneizubereitung
DZ2462A1 (fr) Vaccin antigrippal.
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE298571T1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
BR0015188A (pt) Composições farmacêuticas
ATE404207T1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
DE59915033D1 (de) Pharmazeutische Zubereitung
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
DE59903028D1 (de) Levothyroxin natrium enthaltende pharmazeutische zubereitung
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
NO900297L (no) Vaeskeformig farmasoeytisk preparat inneholdende piperidinoalkanolderivater.
DE19681529D2 (de) Pharmazeutische Darreichungsform
AR023056A1 (es) Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
DE69904021D1 (de) Flüsige pharmazeusche zubereitung enthaltend zotepin
ECSP003570A (es) Derivados de 2- bencil-3-dimetilamino-1-fenil- propano
ATE235255T1 (de) Tezosentan enthaltende wässerige pharmazeutische zubereitung